WEBINAR: Rescheduling Cannabis is Back on the Table
Gain valuable insights for banking this evolving industry!
Wednesday, March 11, 2026
1:00 pm ET, 10:00 am PT
$149, includes Live Event and Recorded Playback without expiration
Federal cannabis rescheduling has been widely interpreted as a turning point for banking access and compliance clarity. In reality, the current regulatory environment remains legally incomplete and operationally fragmented. While rescheduling may eventually unlock tax, research, and market benefits, it does not standardize state frameworks, mandate banking participation, or eliminate examiner discretion. For financial institutions, this disconnect between policy intent and practical implementation introduces new layers of risk rather than immediate relief.
As rescheduling progresses through a prolonged and uncertain rulemaking process, banks face heightened complexity across payments, product classification, and compliance oversight. Ambiguities around product thresholds, Controlled Substances Act overlap, and examiner expectations place increased pressure on compliance teams to demonstrate defensible controls. Institutions that rely on policy assumptions rather than infrastructure risk exposure if regulatory momentum stalls, reverses, or is challenged.
This session will help banking, compliance, and regulatory professionals understand what has actually changed, what has not, and why resilient compliance infrastructure matters more than regulatory headlines. Attendees will leave with a clear framework for navigating a reversible regulatory environment while maintaining examiner-defensible operations regardless of future policy outcomes.